Acuta Capital Partners’s Immunovant IMVT Stock Holding History

Acuta Capital Partners’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$2.98M	Sell
2023 Q4	$5.03M	Sell
2023 Q3	$4.95M	Sell
2023 Q2	$2.69M	Buy
2021 Q1	–	Sell
2020 Q4	$13.1M	Buy
2020 Q3	$8.8M	Sell
2020 Q2	$8.52M	Buy